Heiko Konig

  • 835 Citations
  • 14 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Heiko Konig is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


  • 835 Citations
  • 14 h-Index
  • 17 Article
  • 6 Review article
  • 1 Letter

Combination of sorafenib, vorinostat and bortezomib for the treatment of poor-risk AML: report of two consecutive clinical trials

Sayar, H., Cripe, L. D., Saliba, A. N., Abu Zaid, M., Konig, H. & Boswell, H. S., Feb 2019, In : Leukemia Research. 77, p. 30-33 4 p.

Research output: Contribution to journalLetter

3 Scopus citations

Consecutive epigenetically-active agent combinations act in ID1-RUNX3-TET2 and HOXA pathways for Flt3ITD+ve AML

Sayar, H., Liu, Y., Gao, R., Zaid, M. A., Cripe, L. D., Weisenbach, J., Sargent, K. J., Nassiri, M., Li, L., Konig, H., Suvannasankha, A., Pan, F., Shanmugam, R., Goswami, C., Kapur, R., Xu, M. & Scott Boswell, H., Jan 1 2018, In : Oncotarget. 9, 5, p. 5703-5715 13 p.

Research output: Contribution to journalArticle

  • 1 Scopus citations

    The rocky road to personalized medicine in acute myeloid leukaemia

    Brinda, B., Khan, I., Parkin, B. & Konig, H., Mar 2018, In : Journal of Cellular and Molecular Medicine. 22, 3, p. 1411-1427 17 p.

    Research output: Contribution to journalReview article

  • 8 Scopus citations

    A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML

    Knapper, S., Russell, N., Gilkes, A., Hills, R. K., Gale, R. E., Cavenagh, J. D., Jones, G., Kjeldsen, L., Grunwald, M. R., Thomas, I., Konig, H., Levis, M. J. & Burnett, A. K., Mar 2 2017, In : Blood. 129, 9, p. 1143-1154 12 p.

    Research output: Contribution to journalArticle

  • 56 Scopus citations

    Enzyme-immobilized hydrogels to create hypoxia for in vitro cancer cell culture

    Dawes, C. S., Konig, H. & Lin, C. C., Apr 20 2017, In : Journal of Biotechnology. 248, p. 25-34 10 p.

    Research output: Contribution to journalArticle

  • 5 Scopus citations